Bulbus Fritillariae Cirrhosae as a Respiratory Medicine: Is There a Potential Drug in the Treatment of COVID-19?

Bulbus Fritillariae Cirrhosae as a Respiratory Medicine: Is There a Potential Drug in the Treatment of COVID-19?

Bulbus fritillariae cirrhosae (BFC) is one of the most used Chinese medicines for lung disease, and exerts antitussive, expectorant, anti-inflammatory, anti-asthmatic, and antioxidant effects, which is an ideal therapeutic drug for respiratory diseases such as ARDS, COPD, asthma, lung cancer, and pu...

Full description

Bibliographic Details
Main Authors: Yunyun Quan, Li Li, Zhujun Yin, Shilong Chen, Jing Yi, Jirui Lang, Lu Zhang, Qianhua Yue, Junning Zhao
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-01-01
Series:Frontiers in Pharmacology
Subjects:
bulbus fritillariae cirrhosae
alkaloids
respiratory diseases
signaling pathways
targets
COVID-19
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2021.784335/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2021.784335/full

Similar Items